The Effect of Medroxyprogesterone Acetate on Angiogenesis in Complex Endometrial Hyperplasia

By Abulafia O.   Triest W.E.   Adcock J.T.   Sherer D.M.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 193-198

Elsevier

Access to resources Recommend Favorite

Progestin therapy for endometrial cancer: The potential of fourth-generation progestin (Review)

By Banno Kouji   Kisu Iori   Yanokura Megumi   Tsuji Kosuke   Masuda Kenta   Ueki Arisa   Kobayashi Yusuke   Yamagami Wataru   Nomura Hiroyuki   Susumu Nobuyuki   Aoki Daisuke  

International Journal of Oncology, Vol. 40, Iss. 6, 2012-06 ,pp. : 1755-1762

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer-a multicentre, open, controlled, prospectively randomised trial

By von Minckwitz G.   Loibl S.   Brunnert K.   Kreienberg R.   Melchert F.   Mosch R.   Neises M.   Schermann J.   Seufert R.   Stiglmayer R.   Stosiek U.   Kaufmann   for the South West German Gynecologic Oncology Group SWGGOG  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2265-2271

Elsevier

Access to resources Recommend Favorite

Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma

By                    

Oncology Letters, Vol. 3, Iss. 5, 2012-01 ,pp. : 1002-1006

Spandidos Publications

Access to resources Recommend Favorite

Longterm exposure to gefitinib induces acquired resistance through DNA methylation changes in the EGFRmutant PC9 lung cancer cell line

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 430-436

Spandidos Publications

Access to resources Recommend Favorite